Prime Medicine, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-5.5M | $-6.2M | $639.0K | $391.0K |
| FY2021 | $-34.1M | $-38.2M | $4.2M | $1.7M |
| FY2022 | $-131.8M | $-147.9M | $16.1M | $6.5M |
| FY2023 | $-165.4M | $-174.1M | $8.7M | $13.9M |
| FY2024 | $-122.9M | $-130.2M | $7.3M | $26.1M |
| FY2025 | $-162.6M | $-167.1M | $4.5M | $29.3M |
Big companies have small moves, small companies have big moves.